BYAH Park Ha Biological Technology Co., Ltd. Ordinary Shares
USConsumer CyclicalAs of 2026-10-09
Why BYAH matters now
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) is a US stock in Consumer Cyclical. The latest InvestLog snapshot shows $2.42 with -2.62% on the session and $1.8M in market capitalization; recent performance reads 1-month +21.10% and YTD -83.40%.
The latest financial table shown here is Q4 2025, with revenue of $1.3M, net income of $-4.5M, and EPS of $-7.61. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -0.3%.
The latest indexable market news headline is "Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm" from GlobeNewsWire.
Additional event context on this page matters because recent insider activity includes Sheng Qixiong filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.20
P/S
0.35
EV/EBITDA
0.11
DCF Value
$-8.06
FCF Yield
-0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
90.6%
Operating Margin
-956.5%
Net Margin
-965.0%
ROE
-591.0%
ROA
-409.3%
ROIC
-578.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.3M | $-4.5M | $-7.61 |
| FY 2025 | $2.5M | $-24.4M | $-41.38 |
| Q2 2025 | $1.2M | $-19.8M | $-33.76 |
| Q1 2025 | $1.2M | $-19.8M | $-34.00 |
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Consumer Cyclical
Industry
Personal Products & Services
Country
CN
Exchange
—
Beta
-0.29
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.